<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AiM</journal-id><journal-title-group><journal-title>Advances in Microbiology</journal-title></journal-title-group><issn pub-type="epub">2165-3402</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/aim.2024.142009</article-id><article-id pub-id-type="publisher-id">AiM-131194</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Phenotypic Detection of Enterobacterales Strains Susceptible of Producing OXA-48 Carbapenemase
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoulaye</surname><given-names>Seck</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdou</surname><given-names>Diop</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Babacar</surname><given-names>Ndiaye</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Assane</surname><given-names>Dieng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Awa</surname><given-names>Ba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amadou</surname><given-names>Diop</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chantal</surname><given-names>Mahou Douala-Djemba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Thierno</surname><given-names>Abdoulaye Diallo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Cheikh Anta Diop University of Dakar, Dakar, Senegal</addr-line></aff><aff id="aff2"><addr-line>Medical Biology Laboratory, Pasteur Institute of Dakar, Dakar, Senegal</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>02</month><year>2024</year></pub-date><volume>14</volume><issue>02</issue><fpage>115</fpage><lpage>121</lpage><history><date date-type="received"><day>27,</day>	<month>October</month>	<year>2023</year></date><date date-type="rev-recd"><day>16,</day>	<month>February</month>	<year>2024</year>	</date><date date-type="accepted"><day>19,</day>	<month>February</month>	<year>2024</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background:</b> Nowadays, emergence of Carbapenemase-Producing Enterobacterales (CPE) throughout the world has become a public health problem, especially in countries with limited resources. In recent years, CPE of type OXA-48 (Ambler class D) have been identified in Dakar. The aim of this study was to evaluate the phenotypic detection of OXA-48 CPE using a temocillin disc (30 μg). 
  <b>Methodology:</b> A retrospective study was carried out at Medical Biology Laboratory of Pasteur Institute in Dakar on Ertapenem-Resistant Enterobacterales (ERE) strains isolated from 2015 to 2017. These strains were then tested with a 30 μg temocillin disc. Any strain resistant to temocillin (inhibition diameter &lt; 12 mm) was considered to be OXA-48 CPE. Confirmation of OXA-48 CPE was performed by PCR and sequencing. 
  <b>Results:</b> Forty-one ERE isolated during the study period were tested, of which 34 (82.9%) were OXA-48 based on phenotypic detection using temocillin disc and confirmed by PCR (100%). OXA-48 CPE strains detected were composed of 
  Klebsiella pneumoniae (n = 14; 41.2%), 
  Enterobacter cloacae (n = 8; 23.5%), 
  Escherichia coli (n = 7, 20.5%), 
  Citrobacter freundii (n = 3; 8.8%), 
  Cronobacter sakazakii (n = 1; 3%) and 
  Morganella morganii (n = 1; 3%). 
  <b>Conclusion:</b> Temocillin resistance has a good positive predictive value for detecting OXA-48 CPE by phenotypic method, confirmed by PCR. Temocillin is therefore a good marker for detection of OXA-48 CPE except 
  Hafnia alvei.
 
</p></abstract><kwd-group><kwd>Ertapenem</kwd><kwd> Temocillin</kwd><kwd> Phenotypic Detection</kwd><kwd> Carbapenemase-Producing Enterobacterales</kwd><kwd> OXA-48</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Bacterial resistance to antibiotics is steadily increasing and constitutes a global public health problem. According to estimates by World Health Organization (WHO), human and economic impacts of antimicrobial resistance between now and 2050 will be considerable [<xref ref-type="bibr" rid="scirp.131194-ref1">1</xref>] . Over last ten years, emergence and spread of Carbapenem-Resistant Enterobacterales (CRE) and, in particular, Klebsiella pneumoniae, have become worldwide [<xref ref-type="bibr" rid="scirp.131194-ref2">2</xref>] .</p><p>Carbapenems are antibiotics of choice for serious infections caused by multi-resistant gram-negative bacteria [<xref ref-type="bibr" rid="scirp.131194-ref3">3</xref>] . CRE can cause treatment failures and constitute a major public health problem [<xref ref-type="bibr" rid="scirp.131194-ref4">4</xref>] . Resistance due to production of a carbapenemase is transferred horizontally among Enterobacteriaceae, and there are many types of carbapenemases: clavulanic acid-inhibited &#223;-lactamases (Class A: KPC, NMC, IMI, SME and GES), metallo-betalactamases (Class B: IMP, VIM, NDM, GIM, SPM and SIM) and extended-spectrum oxacillinases (Class D: OXA-48-like) [<xref ref-type="bibr" rid="scirp.131194-ref5">5</xref>] . With exception of OXA-48, these enzymes confer high resistance to most beta-lactam compounds such as penicillins and cephalosporins, but affect carbapenems to a variable extent [<xref ref-type="bibr" rid="scirp.131194-ref6">6</xref>] . OXA-type carbapenemases are considered to be penicillinases capable of hydrolyzing oxacillin and cloxacillin and are weakly inhibited by clavulanic acid and EDTA. OXA-48 is one of the few members of this family to have significant carbapenem hydrolysis activity [<xref ref-type="bibr" rid="scirp.131194-ref7">7</xref>] .</p><p>OXA-48 carbapenemases have been frequently reported in North African and other Mediterranean countries [<xref ref-type="bibr" rid="scirp.131194-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.131194-ref7">7</xref>] . In Morocco, an increased spread of OXA-48-producing Enterobacteriaceae isolates linked to healthcare-associated infections has been reported [<xref ref-type="bibr" rid="scirp.131194-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.131194-ref9">9</xref>] .</p><p>In Senegal, emergence of plasmid-encoded bla<sub>OXA-48</sub> gene has been reported in multi-resistant Enterobacteriaceae of community and hospital origin in Dakar [<xref ref-type="bibr" rid="scirp.131194-ref10">10</xref>] . Detection of OXA-48 carbapenemases remains difficult due to multitude of phenotypes and resistance mechanisms [<xref ref-type="bibr" rid="scirp.131194-ref11">11</xref>] . A phenotypic test for detection of OXA-48 CPE has been proposed with temocillin disc. Temocillin is a derivative of ticarcillin (6-α-methoxy ticarcillin) which has a narrow spectrum for enterobacteria and is not hydrolyzed by β-lactamases (ESBL, AmpC) and cephalosporinases. Hafnia alvei has natural resistance to temocillin [<xref ref-type="bibr" rid="scirp.131194-ref12">12</xref>] .</p><p>The aim of this study was to use a phenotypic identification method to detect OXA-48 CPE in strains of Enterobacteriaceae isolated in Dakar.</p></sec><sec id="s2"><title>2. Material and Methods</title><sec id="s2_1"><title>2.1. Bacterial Strains</title><p>This retrospective study was carried out at Medical Biology Laboratory of Pasteur Institute in Dakar on enterobacteria strains isolated from 2015 to 2017. Strains resistant to ertapenem (10 &#181;g) with an inhibition diameter of less than 25 mm according to EUCAST 2020 recommendations were included in the study. Phenotypic detection of OXA-48 CPE was performed using temocillin disc (30 &#181;g).</p></sec><sec id="s2_2"><title>2.2. Phenotypic Detection of Resistance to Temocillin</title><p>Antibiotic susceptibility profiling was performed using Mueller-Hinton agar diffusion method (Becton Dickinson, Heidelberg, Germany) with antibiotic disc temocillin (30 &#181;g) according to guidelines of the European Committee of Antimicrobial Susceptibility Testing (EUCAST, 2020).</p></sec><sec id="s2_3"><title>2.3. Molecular Confirmation</title><p>Presence of OXA-48 CPE was confirmed by PCR using following specific primers.</p><p>O48-F CCA AGC ATT TTT ACC CGC ATC KAC C</p><p>O48-R GYT TGA CCA TAC GCT GRC TGC G</p><p>PCR and sequencing were performed searching of bla<sub>OXA-48</sub> gene as described previously [<xref ref-type="bibr" rid="scirp.131194-ref13">13</xref>] .</p><p>Control strain NCTC-13442 was used as a reference.</p></sec><sec id="s2_4"><title>2.4. Data Analysis</title><p>Data were entered and analysed using Excel 2018 and logiciel R. We estimated the sensitivity, specificity and kappa coefficient of the phenotypic test in reference to PCR.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Bacterial Strains</title><p>Forty-one strains of enterobacteria isolated from various pathological samples were analysed for this study. These strains were mainly composed of K. pneumoniae (n = 16), E. coli (n = 11) and E. cloacae (n = 9) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of enterobacteria strains tested</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Strains</th><th align="center" valign="middle"  colspan="2"  >Number %</th></tr></thead><tr><td align="center" valign="middle" >K. pneumoniae</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >39</td></tr><tr><td align="center" valign="middle" >E. coli</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >26.9</td></tr><tr><td align="center" valign="middle" >E. cloacae</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >22</td></tr><tr><td align="center" valign="middle" >C. freundii</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >7.3</td></tr><tr><td align="center" valign="middle" >C. sakazakii</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >M. morganii</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap></sec><sec id="s3_2"><title>3.2. Resistance to Ertapenem</title><p>Antibiotic susceptibility profiling by diffusion method showed that all strains of enterobacteria were resistant to ertapenem. Inhibition diameters range from 8 to 21 mm depending on the species (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Enterobacteria strains resistant to ertapenem</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Strains</th><th align="center" valign="middle"  colspan="2"  >Profil to ertapenem</th></tr></thead><tr><td align="center" valign="middle" >Diameter range (mm)</td><td align="center" valign="middle" >Resistant</td></tr><tr><td align="center" valign="middle" >K. pneumoniae</td><td align="center" valign="middle" >8 - 20</td><td align="center" valign="middle" >16</td></tr><tr><td align="center" valign="middle" >E. coli</td><td align="center" valign="middle" >8 - 23</td><td align="center" valign="middle" >11</td></tr><tr><td align="center" valign="middle" >E. cloacae</td><td align="center" valign="middle" >8 - 17</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >C. freundii</td><td align="center" valign="middle" >10 - 15</td><td align="center" valign="middle" >3</td></tr><tr><td align="center" valign="middle" >M. morganii</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >C. sakazakii</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >1</td></tr></tbody></table></table-wrap></sec><sec id="s3_3"><title>3.3. Resistance to Temocillin</title><p>Of the 41 strains resistant to ertapenem, 34 isolates were resistant to temocillin (<xref ref-type="table" rid="table1">Table 1</xref>), and therefore suspected of being EPC probably type OXA-48.</p><p>These isolates included K. pneumoniae (n = 14), E. cloacae (n = 8), E. coli (n = 7), C. freundii (n = 3), C. sakazakii (n = 1) and M. morganii (n = 1).</p></sec><sec id="s3_4"><title>3.4. Resistance of PCR and Sequencing of bla<sub>OXA-48</sub></title><p>All strains both resistant to ertapenem and temocillin harbored OXA-48 gene (<xref ref-type="table" rid="table2">Table 2</xref>). Sequencing confirmed presence of OXA-48 gene in all 34 temocillin-resistant isolates (<xref ref-type="table" rid="table3">Table 3</xref>): GenBank accession numbers NG049762.1 (n = 31) and NG 049482.1 (n = 3).</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Temocillin-resistant strains of enterobacteria harboring the OXA-48 gene</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Strains</th><th align="center" valign="middle"  colspan="4"  >Profil to temocillin</th><th align="center" valign="middle"  colspan="2"  >OXA-48 gene</th></tr></thead><tr><td align="center" valign="middle" >Diameter range (mm)</td><td align="center" valign="middle" >R</td><td align="center" valign="middle" >I</td><td align="center" valign="middle" >S</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >Negative</td></tr><tr><td align="center" valign="middle" >K. pneumoniae</td><td align="center" valign="middle" >6 - 26</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >E. coli</td><td align="center" valign="middle" >6 - 26</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >E. cloacae</td><td align="center" valign="middle" >6 - 24</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1</td></tr><tr><td align="center" valign="middle" >C. freundii</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >M. morganii</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >C. sakazakii</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >7</td></tr></tbody></table></table-wrap><p>R: resistant, I: intermediate, S: sensitive.</p></sec><sec id="s3_5"><title>3.5. Comparison Temocillin Resistance versus PCR</title><p>This study showed a sensitivity of 100% (95% CI: 0.90 - 1.0), a specificity of 100% (95% CI: 0.54 - 1.0), and a kappa coefficient equal to 1 for the phenotypic test compared with PCR (<xref ref-type="table" rid="table4">Table 4</xref>).</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Comparison of phenotypic detection with temocillin disk versus</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >PCR (reference test)</th><th align="center" valign="middle"  rowspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >OXA-48 presence</td><td align="center" valign="middle" >OXA-48 absence</td></tr><tr><td align="center" valign="middle" >Temocillin R</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >34</td></tr><tr><td align="center" valign="middle" >Temocillin S or I</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >41</td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><p>The aim of this study was to evaluate phenotypic detection of OXA-48 CPE strains isolated from 2015 to 2017 with a temocillin disc (30 &#181;g). Confirmation was made by PCR for reschearch of OXA-48 gene.</p><p>Forty-one enterobacteria strains resistant to ertapenem (inhibition diameter &lt; 22 mm, EUCAST 2020) were analyzed. Temocillin resistance was found in 83% of isolates (n = 34), suggesting a probable CPE type OXA-48. Molecular analysis of these strains confirmed the presence of OXA-48 gene in all temocillin-resistant isolates. For strains resistant to ertapenem, other carbapenem resistance genes (KPC, IMP, VIM, NDM, IMI, GES, etc.) should also be checked.</p><p>In Senegal, the circulation of enterobacteria strains harboring bla<sub>OXA-48</sub> gene isolated in community and hospital settings has been reported since 2011 [<xref ref-type="bibr" rid="scirp.131194-ref10">10</xref>] . These CPE type OXA-48 are endemic in several African countries, including North Africa, T&#252;rkiye, Arabian Peninsula and India [<xref ref-type="bibr" rid="scirp.131194-ref14">14</xref>] .</p><p>In France in 2020, OXA-48 carbapenemases accounted for 63.3% of EPCs in circulation according to data from National Reference Center [<xref ref-type="bibr" rid="scirp.131194-ref15">15</xref>] .</p><p>In this study, 14 strains of K. pneumoniae (41%) produced carbapenemase type OXA-48. The spread of K. pneumoniae strains harboring genes encoding resistance to carbapenems has been described throughout the world [<xref ref-type="bibr" rid="scirp.131194-ref16">16</xref>] .</p><p>The increasing use of carbapenems in clinical practice is being followed by emergence of CPE, which are increasingly being detected throughout the world, and this trend has been observed in Senegal. Emergence of carbapenemases acquired from enterobacteria appeared early in Senegal (2008) after introduction of imipenem, and their frequency is probably underestimated, partly because of limited number of bacteriology laboratories equipped with qualified staff [<xref ref-type="bibr" rid="scirp.131194-ref17">17</xref>] . Multiple antibiotic resistance is prevalent among enterobacteria strains isolated in rural communities [<xref ref-type="bibr" rid="scirp.131194-ref18">18</xref>] , but especially in hospitals in Dakar where emergence of CPE harboring the bla<sub>OXA-48</sub> gene is a major concern.</p><p>Sensitivity and specificity of phenotypic test using temocillin disk were 100% in reference to PCR detection of the bla<sub>OXA-48</sub> gene. The good sensitivity and specificity of phenotypic test with temocillin may be a means of rapidly detecting ertapenem-resistant enterobacteria strains likely to be OXA-48 carbapenemase producers, and of managing patients infected with these strains. In fact, this test does not require any investment on the part of the laboratory, compared to the molecular biology technique, which is not accessible to most laboratories in developing countries, and also to rapid diagnostic test, which despite its lower cost is not yet within the reach of these laboratories. All strains of enterobacteria resistant to ertapenem and temocillin require confirmation of OXA-48 carbapenemase production by rapid diagnostic method (immunoassay) or molecular technique.</p><p>This study has some limitations, notably the fact that it only detects OXA-48 type carbapenemases and therefore cannot identify other classes of carbapenemases.</p><p>However, some bacterial species are naturally resistant to temocillin (e.g. Hafnia alvei), and other (fairly rare) mechanisms can induce resistance to this antibiotic.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The phenotypic test with temocillin disk has shown good sensitivity and specificity for detecting ertapenem-resistant enterobacteria strains likely to produce an OXA-48 carbapenemase. However, identification of carbapenemase type must be carried out by a rapid diagnostic method (immunoassay) or by PCR.</p></sec><sec id="s6"><title>Authors’ Contributions</title><p>AS designed the study and revised manuscript version. AD and BN participated susceptibility testing and molecular test. CT carried out statistical analyses. All authors have read and approved final version of manuscript.</p></sec><sec id="s7"><title>Acknowledgements</title><p>Medical Biology Laboratory of Pasteur Institute of Dakar (IPD).</p></sec><sec id="s8"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec id="s9"><title>Cite this paper</title><p>Seck, A., Diop, A., Ndiaye, B., Dieng, A., Ba, A., Diop, A., Douala-Djemba, C.M. and Diallo, T.A. (2024) Phenotypic Detection of Enterobacterales Strains Susceptible of Producing OXA-48 Carbapenemase. Advances in Microbiology, 14, 115-121. https://doi.org/10.4236/aim.2024.142009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.131194-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">OMS (2017) Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. https://remed.org/wp-content/uploads/2017/03/lobal-priority-list-of-antibiotic-resistant-bacteria-2017.pdf</mixed-citation></ref><ref id="scirp.131194-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Nordmann, P. and Poirel, L. (2014) The Difficult-to-Control Spread of Carbapenemase Producers among Enterobacteriaceae Worldwide. Clinical Microbiology and Infection, 20, 821-830. https://doi.org/10.1111/1469-0691.12719</mixed-citation></ref><ref id="scirp.131194-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Patel, G., Huprikar, S., Factor, S.H., Jenkins S.G. and Calfee, D.P. (2008) Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies. Infection Control &amp; Hospital Epidemiology, 29, 1099-1106. https://doi.org/10.1086/592412</mixed-citation></ref><ref id="scirp.131194-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Potron, A., Poirel, L., Rondinaud, E. and Nordmann, P. (2013) Intercontinental Spread of OXA-48 Beta-Lactamase-Producing Enterobacteriaceae over a 11-Year Period, 2001 to 2011. Eurosurveillance, 18, Article 20549. https://doi.org/10.2807/1560-7917.ES2013.18.31.20549</mixed-citation></ref><ref id="scirp.131194-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Nordmann, P., Cuzon, G. and Naas, T. (2009) The Real Threat of Klebsiella pneumoniae Carbapenemase-Producing Bacteria. The Lancet Infectious Diseases, 9, 228-236. https://doi.org/10.1016/S1473-3099(09)70054-4</mixed-citation></ref><ref id="scirp.131194-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Poirel, L., Potron, A. and Nordmann, P. (2012) OXA-48-Like Carbapenemases: The Phantom Menace. Journal of Antimicrobial Chemotherapy, 67, 1597-1606. https://doi.org/10.1093/jac/dks121</mixed-citation></ref><ref id="scirp.131194-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Poirel, L., Héritier, C., Tolün, V. and Nordmann, P. (2004) Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 48, 15-22. https://doi.org/10.1128/AAC.48.1.15-22.2004</mixed-citation></ref><ref id="scirp.131194-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Hays, C., Benouda, A., Poirel, L., Elouennass, M. and Nordmann, P. (2012) Nosocomial Occurrence of OXA-48-Producing Enterobacterial Isolates in a Moroccan Hospital. International Journal of Antimicrobial Agents, 39, 545-547. https://doi.org/10.1016/j.ijantimicag.2012.03.002</mixed-citation></ref><ref id="scirp.131194-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Poirel, L., Benouda, A., Hays, C. and Nordmann, P. (2011) Emergence of NDM-1-Producing Klebsiella pneumoniae in Morocco. Journal of Antimicrobial Chemotherapy, 66, 2781-2783. https://doi.org/10.1093/jac/dkr384</mixed-citation></ref><ref id="scirp.131194-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Moquet, O., Bouchiat, C., Kinana, A., Seck, A., Arouna, O., Bercion, R., et al. (2011) Class D OXA-48 Carbapenemase in Multidrug-Resistant Enterobacteria, Senegal. Emerging Infectious Diseases, 17, 143-144. https://doi.org/10.3201/eid1701.100244</mixed-citation></ref><ref id="scirp.131194-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">van Duin, D. and Doi, Y. (2017) The Global Epidemiology of Carbapenemase-Producing Enterobacteriaceae. Virulence, 8, 460-469. https://doi.org/10.1080/21505594.2016.1222343</mixed-citation></ref><ref id="scirp.131194-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Laterre, P.F., Wittebole, X., Van de Velde, S., Muller, A.E., Mouton, J.W., Carryn, S., et al. (2015) Temocillin (6 g Daily) in Critically Ill Patients: Continuous Infusion versus Three Times Daily Administration. Journal of Antimicrobial Chemotherapy, 70, 891-898. https://doi.org/10.1093/jac/dku465</mixed-citation></ref><ref id="scirp.131194-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Gr&amp;ouml;bner, S., Linke, D., Schütz, W., Fladerer, C., Madlung, J., Autenrieth, I.B., et al. (2009) Emergence of Carbapenem-Non-Susceptible Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates at the University Hospital of Tübingen, Germany. Journal of Medical Microbiology, 58, 912-922. https://doi.org/10.1099/jmm.0.005850-0</mixed-citation></ref><ref id="scirp.131194-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Dortet, L., Poirel, L. and Nordmann, P. (2013) épidémiologie, détection et identification des entérobactéries productrices de carbapénèmases. Feuillets de Biologie, 312, 1-13.</mixed-citation></ref><ref id="scirp.131194-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Jousset, A.B., Emeraud, C., Bonnin, R.A., Naas, T. and Dortet, L. (2021) Caractéristiques et évolution des Souches d’Entérobactéries Productrices de Carbapénémases (EPC) Isolées en France, 2012-2020. [Characteristics and Evolution of Carbapenemase-Producing Enterobacterales in France, 2012-2020]. Bulletin Epidémiologique Hebdomadaire, 18, 351-358.</mixed-citation></ref><ref id="scirp.131194-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Nordmann, P., Dortet, L. and Poirel, L. (2012) Carbapenem Resistance in Enterobacteriaceae: Here Is the Storm! Trends in Molecular Medicine, 18, 263-272. https://doi.org/10.1016/j.molmed.2012.03.003</mixed-citation></ref><ref id="scirp.131194-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Petti, C.A., Polage, C.R., Quinn, T.C., Ronald, A.R. and Sande, M.A. (2006) Laboratory Medicine in Africa: A Barrier to Effective Health Care. Clinical Infectious Diseases, 42, 377-382. https://doi.org/10.1086/499363</mixed-citation></ref><ref id="scirp.131194-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ruppé, E., Woerther, P.L., Diop, A., Sene, A.M., Da Costa, A., Arlet, G., et al. (2009) Carriage of CTX-M-15-Producing Escherichia coli Isolates among Children Living in a Remote Village in Senegal. Antimicrobial Agents and Chemotherapy, 53, 3135-3137. https://doi.org/10.1128/AAC.00139-09</mixed-citation></ref></ref-list></back></article>